Study of plasma changes after ovarian reactivation treatment
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how a treatment called StemCell Regenera, which uses a growth factor medicine (Filgrastim), affects the blood of women with poor ovarian response or low egg reserve. The goal is to understand how the treatment might help reactivate the ovaries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 43 years old.
- You have been diagnosed with poor ovarian response or low ovarian reserve (according to standard medical criteria).
- Your doctor has recommended the StemCell Regenera procedure with a medicine called Filgrastim.
- You agree to take part in the study and sign a consent form.
- You do not have only one ovary, an autoimmune or blood disorder, or an allergy to Filgrastim.
- You are not currently taking blood-thinning medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting a woman's own cells into her ovaries can help improve egg production for women with very low ovarian reserve. It is for women under 45 who have had poor results from IVF in the past.
This trial tests whether injecting your own platelet-rich plasma (PRP) into the ovaries can improve egg retrieval and embryo development for women who have had very few eggs or no transplantable embryos in previous IVF cycles.
This trial tests whether injecting platelet-rich plasma (a concentrate from your own blood) into the uterus or ovaries can help women with certain fertility issues, such as damaged uterine lining, scarring, or low egg reserve. It aims to improve pregnancy chances in these challenging cases.
This trial studies whether an injection of your own “platelet-rich” plasma into the ovaries can improve egg production in people who respond poorly to fertility treatment. It targets women with low egg reserve and tries to see if this approach helps them get better results from stimulation.
This trial tests whether injecting your own platelet-rich plasma (PRP) into the ovaries can improve egg production in people who don’t respond well to fertility stimulation. It may help some “poor responders” get more usable eggs for IVF.
This trial studies whether an injection of your own PRP (platelet-rich plasma) can improve how your ovaries work in people with early ovarian failure. If it helps, it may lead to better hormone balance and return of more regular ovulation and periods.
Hear when a new Poor Ovarian Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.